A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors

Andrea Wang-Gillam, Susanne M. Arnold, Ronald M. Bukowski, Mace L. Rothenberg, Wendy Cooper, Kenneth K. Wang, Eric Gauthier, A. Craig Lockhart

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science